Celldex Therapeutics, Inc.

Q4 2022 13F Holders

Symbol
CLDX
CUSIP
15117B202
Type
Equity
Class
COM NEW
Num filers
170
Total reported value, excl. options
$2.17B
Manager Report Date Value ($000) Shares